A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
Clinical trial NCT03425591 · COMPLETED
Trial details
- NCT number
- NCT03425591
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-11
- Primary completion
- 2022-08-11
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.